Hims & Hers Health Plummets to 20th in Trading Volume with $22.13 Billion Decline

On May 19, 2025, Hims & Hers Health (HIMS) experienced a significant decline, with a trading volume of $22.13 billion, marking a 30.77% decrease from the previous day. This placed Hims in the 20th position in terms of trading volume for the day, and the stock price dropped by 3.57%.

Hims & Hers Health, Inc. (HIMS) has announced that it will be hosting its first-ever investor day on June 12, 2025. The event will provide an opportunity for investors to gain insights into the company's strategic vision, growth opportunities, and financial performance. The investor day will feature presentations from the company's senior leadership team, including CEO Andrew Dudum, who will discuss the company's long-term goals and initiatives to drive shareholder value.

Hims & Hers Health, Inc. (HIMS) has recently expanded its telehealth services to include mental health support. The company has partnered with several mental health professionals to offer virtual therapy sessions, counseling services, and other resources to help individuals manage their mental health. This expansion is part of Hims' broader strategy to provide comprehensive healthcare solutions to its customers, addressing both physical and mental health needs.

Hims & Hers Health, Inc. (HIMS) has also announced the launch of a new line of skincare products designed specifically for men. The new product line includes a range of cleansers, moisturizers, and serums formulated to address common skin concerns such as acne, aging, and hyperpigmentation. The launch of this new product line is part of Hims' ongoing efforts to expand its product offerings and cater to the unique needs of its male customers.